March 2007 - AudioMedica.com

Monthly Archive: March 2007

0
- in Cardiovascular
- — 27 Mar, 2007
Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World
WILLIAM GRAY, Columbia University, New York
REFERENCE: Abstract 2409-5, American College of Cardiolgy New Orleans
The benefits of carotid stenting as compared with surgery have been maintained in real-world settings since USA-approval of the technique in 2004, according to William
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering
SUZANNE OPARIL, University of Alabama, Birmingham
REFERENCE: Abstract 405-12, American College of Cardiolgy New Orleans
A combination of two antihypertensive agents has given improved blood pressure control in a study with nearly 2000 patients reported to the ACC meeting in
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
“RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
JOHN KASTELEIN, Academic Medical Center, Amsterdam
REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans
A drug which raises HDL and reduces circulating levels of LDL has nevertheless failed to reduce atherosclerotic progression in patients with familial hypercholesterolemia. This disappointing
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
“ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
JEAN-CLAUDE TARDIF, Montreal Heart Institute
REFERENCE: Abstract 405-10, American College of Cardiolgy New Orleans
Improvements in atheroma plaque have been achieved by infusing patients who have acute coronary syndromes with reconstituted high density lipoprotein, HDL, according to investigators from the
…
Read more
1
- in Cardiovascular
- — 26 Mar, 2007
COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
STEVEN NISSEN, Cleveland Clinic, OH
REFERENCE: N Engl J Med 2007 356
Reporting from: American College of Cardiolgy New Orleans
Two big studies published in the New England Journal of Medicine and presented simultaneously at the American College of Cardiology
…
Read more
0
- in Cardiovascular
- — 26 Mar, 2007
Bioabsorbable Everolimus-Eluting Stent: 6-Month Angiographic and IVUS Results

Patrick Serruys

Spencer King
PATRICK SERRUYS, Erasmus University, Rotterdam
COMMENT: SPENCER KING, Piedmont Hospital, Atlanta
REFERENCE: Abstract 2402-3, American College of Cardiology New Orleans
Six-months follow-up of patients receiving a new bioabsorbable drug-eluting stent are favourable, according to Patrick Serruys
…
Read more
0
- in Cardiovascular
- — 26 Mar, 2007
Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction

Soko Setoguchi

Douglas Zipes
SOKO SETOGUCHI, Brigham And Women’s Hospital, Boston
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis
REFERENCE: Abstract 1018-148, American College of Cardiology New Orleans
The increased adherence to recommendations and guidelines for drug therapy after myocardial infarction
…
Read more
0
- in Cardiovascular
- — 25 Mar, 2007
Rapid Genotype Assay for Individualized Warfarin Dosing

Jeffrey Anderson

Douglas Zipes
JEFFREY ANDERSON, University of Utah, Salt Lake City
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis
REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans
The hope of refining treatments for cardiovascular disease by genotyping patients to
…
Read more
0
- in Cardiovascular
- — 25 Mar, 2007
Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
DAVID MOLITERNO, University of Kentucky, Lexington
REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials
An oral thrombin receptor antagonist, SCH 530348 has proved safe and effective, and may be better than conventional anti-coagulation treatments for patients
…
Read more
0
- in ASCO · Oncology
- — 16 Mar, 2007
When Good Cells Go Bad: The Stem Cell Origin of Cancers
DAVID JABLONS, University of California, San Francisco
REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain
Cell signalling using the Wnt pathway may hold the key to many, if not all, the genetic pathways to cancer,
…
Read more
0
- in Public Health
- — 15 Mar, 2007
6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates
HOOSEN COOVADIA, University of KwaZulu-Natal, Durban
REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
In the developing world breastfeeding is the recommended infant feeding method, even for women infected with HIV. While early
…
Read more
0
- in Public Health
- — 13 Mar, 2007
Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety
HOWARD MAYER, Pfizer Global Research, New London CT
MARK WAINBERG, McGill University, Montreal
Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
In a population of treatment-experienced HIV-infected subjects, maraviroc plus optimised background
…
Read more

Monthly Archive: March 2007

Sign up for AudioMedica.com news